Oral administration of carbonic anhydrase I ameliorates murine experimental colitis induced by Foxp3-CD4+CD25- T cells

Journal of Leukocyte Biology

Volumn 93, Issue 6, 2013, Pages 963-972

  Mori, Kenichirou ^a   Yamanishi, Hirofumi ^b   Ikeda, Yoshiou ^b   Kumagi, Teru ^a   Hiasa, Yoichi ^a   Matsuura, Bunzo ^a   Abe, Masanori ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Aldehyde dehydrogenase family 1a2; CD103+ dendritic cell; Inflammatory bowel disease; Regulatory T cell; Tolerance

Indexed keywords

CARBONATE DEHYDRATASE I; CD103 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 17; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENTERITIS; EPITHELIUM HYPERPLASIA; EX VIVO STUDY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY CELL; INHIBITION KINETICS; LAMINA PROPRIA; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFER; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH17 CELL;

ALDEHYDE DEHYDROGENASE FAMILY 1A2; CD103+ DENDRITIC CELL; INFLAMMATORY BOWEL DISEASE; REGULATORY T CELL; TOLERANCE;

ADMINISTRATION, ORAL; ANIMALS; CARBONIC ANHYDRASE I; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, SCID; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS;

BACTERIA (MICROORGANISMS); MURINAE; MUS;

EID: 84878410625     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1212612     Document Type: Article

References (39)

1. Podolsky, D. K. (2002) Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429.
2. Baumgart, D. C., Carding, S. R. (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369, 1627-1640.
3. Reynoso, E. D., Elpek, K. G., Francisco, L., Bronson, R., Bellemare-Pelletier, A., Sharpe, A. H., Freeman, G. J., Turley, S. J. (2009) Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade. J. Immunol. 182, 2102-2112.
4. Shale, M., Ghosh, S. (2009) How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease. Gut 58, 1291-1299.
5. Huang, F. P., Platt, N., Wykes, M., Major, J. R., Powell, T. J., Jenkins, C. D., MacPherson, G. G. (2000) A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191, 435-444.
6. Huibregtse, I. L., van Lent, A. U., van Deventer, S. J. (2007) Immunopathogenesis of IBD: insufficient suppressor function in the gut? Gut 56, 584-592.
7. Sandborn, W. J. (2008) Current directions in IBD therapy: what goals are feasible with biological modifiers? Gastroenterology 135, 1442-1447.
8. Weiner, H. L., da Cunha, A. P., Quintana, F., Wu, H. (2011) Oral tolerance. Immunol. Rev. 241, 241-259.
9. Thurau, S. R., Fricke, H., Burchardi, C., Diedrichs-Mohring, M., Wildner, G. (2004) Long-term follow-up of oral tolerance induction with HLA-peptide B27PD in patients with uveitis. Ann. N. Y. Acad. Sci. 1029, 408-412.
10. Vehik, K., Cuthbertson, D., Ruhlig, H., Schatz, D. A., Peakman, M., Krischer, J. P., DPT-1 and TrialNet Study Groups (2011) Long-term outcome of individuals treated with oral insulin: diabetes prevention trialtype 1 (DPT-1) oral insulin trial. Diabetes Care 34, 1585-1590.
11. Trentham, D. E., Dynesius-Trentham, R. A., Orav, E. J., Combitchi, D., Lorenzo, C., Sewell, K. L., Hafler, D. A., Weiner, H. L. (1993) Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261, 1727-1730.
12. Weiner, H. L., Mackin, G. A., Matsui, M., Orav, E. J., Khoury, S. J., Dawson, D. M., Hafler, D. A. (1993) Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259, 1321-1324.
13. Tsuji, N. M., Kosaka, A. (2008) Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells. Trends Immunol. 29, 532-540.
14. Margalit, M., Israeli, E., Shibolet, O., Zigmond, E., Klein, A., Hemed, N., Donegan, J. J., Rabbani, E., Goldin, E., Ilan, Y. (2006) A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patienttailored approach. Am. J. Gastroenterol. 101, 561-568.
15. Kraus, T. A., Toy, L., Chan, L., Childs, J., Mayer, L. (2004) Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 126, 1771-1778.
16. Horwitz, D. A., Zheng, S. G., Gray, J. D. (2008) Natural and TGF-β-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol. 29, 429-435.
17. Cong, Y., Brandwein, S. L., McCabe, R. P., Lazenby, A., Birkenmeier, E. H., Sundberg, J. P., Elson, C. O. (1998) CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J. Exp. Med. 187, 855-864.
18. Cong, Y., Weaver, C. T., Lazenby, A., Elson, C. O. (2002) Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 169, 6112-6119.
19. Yamanishi, H., Murakami, H., Ikeda, Y., Abe, M., Kumagi, T., Hiasa, Y., Matsuura, B., Onji, M. (2012) Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4(+)CD25(+) T cells. J. Immunol. 188, 2164-2172.
20. Faria, A. M., Maron, R., Ficker, S. M., Slavin, A. J., Spahn, T., Weiner, H. L. (2003) Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-β/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. J. Autoimmun. 20, 135-145.
21. Kjellev, S., Lundsgaard, D., Poulsen, S. S., Markholst, H. (2006) Reconstitution of Scid mice with CD4+CD25- T cells leads to rapid colitis: an improved model for pharmacologic testing. Int. Immunopharmacol. 6, 1341-1354.
22. Katakura, K., Lee, J., Rachmilewitz, D., Li, G., Eckmann, L., Raz, E. (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Invest. 115, 695-702.
23. Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., Littman, D. R., Reinecker, H. C. (2005) CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307, 254-258.
24. Fonti, R., Latella, G., Caprilli, R., Frieri, G., Marcheggiano, A., Sambuy, Y. (1998) Carbonic anhydrase I reduction in colonic mucosa of patients with active ulcerative colitis. Dig. Dis. Sci. 43, 2086-2092.
25. Renes, I. B., Verburg, M., Van Nispen, D. J., Taminiau, J. A., Buller, H. A., Dekker, J., Einerhand, A. W. (2002) Epithelial proliferation, cell death, and gene expression in experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3 expression. Int. J. Colorectal Dis. 17, 317-326.
26. Coombes, J. L., Siddiqui, K. R., Arancibia-Carcamo, C. V., Hall, J., Sun, C. M., Belkaid, Y., Powrie, F. (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764.
27. Feng, T., Cong, Y., Qin, H., Benveniste, E. N., Elson, C. O. (2010) Generation of mucosal dendritic cells from bone marrow reveals a critical role of retinoic acid. J. Immunol. 185, 5915-5925.
28. Parkkila, S., Parkkila, A. K., Juvonen, T., Rajaniemi, H. (1994) Distribution of the carbonic anhydrase isoenzymes I, II, and VI in the human alimentary tract. Gut 35, 646-650.
29. Ilan, Y., Weksler-Zangen, S., Ben-Horin, S., Diment, J., Sauter, B., Rabbani, E., Engelhardt, D., Chowdhury, N. R., Chowdhury, J. R., Goldin, E. (2000) Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. Am. J. Gastroenterol. 95, 966-973.
30. Worbs, T., Bode, U., Yan, S., Hoffmann, M. W., Hintzen, G., Bernhardt, G., Forster, R., Pabst, O. (2006) Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 203, 519-527.
31. Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., Cheroutre, H. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260.
32. Sun, C. M., Hall, J. A., Blank, R. B., Bouladoux, N., Oukka, M., Mora, J. R., Belkaid, Y. (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785.
33. Li, M. O., Flavell, R. A. (2008) TGF-β: a master of all T cell trades. Cell 134, 392-404.
34. Mucida, D., Kutchukhidze, N., Erazo, A., Russo, M., Lafaille, J. J., Curotto de Lafaille, M. A. (2005) Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115, 1923-1933.
35. Akbari, O., Freeman, G. J., Meyer, E. H., Greenfield, E. A., Chang, T. T., Sharpe, A. H., Berry, G., DeKruyff, R. H., Umetsu, D. T. (2002) Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8, 1024-1032.
36. Weiner, H. L. (2001) The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat. Immunol. 2, 671-672.
37. Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., McKenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., Murphy, E., Sathe, M., Cua, D. J., Kastelein, R. A., Rennick, D. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310-1316.
38. Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., Littman, D. R. (2006) The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133.
39. McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., Cua, D. J. (2007) TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8, 1390-1397.